Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more

See Important Safety Information, including Boxed Warning. How AUSTEDO XR® (deutetrabenazine) extended-release tablets may help.

See Prescribing Information, including Boxed Warning. Find downloadable resources and videos to support you and your patients throughout the treatment journey.

5 days ago · Tardive dyskinesia is a movement disorder caused by antipsychotics and other drugs. Though often permanent, tardive dyskinesia may be reversible with drugs like Ingrezza.

Nov 12, 2025 · New phase 4 data reveals Austedo significantly reduces involuntary movements and enhances quality of life for adults with tardive dyskinesia.

May 30, 2024 · The FDA has approved a new one-pill, once-daily tablet administration option for deutetrabenazine (Austedo XR; Teva Pharmaceuticals), a medication for tardive dyskinesia and …

Tardive Dyskinesia Characteristics: Involuntary movements, usually occurring after months or years of antipsychotic treatment. The most common symptoms are oro-buccal-lingual, such as chewing, lip …

Feb 6, 2026 · Antipsychotic-induced-movement-disorders-can-mimic-tardive-dyskinesia-mdash-learn-key-differences-symptoms-and-diagnostic-clues-for-accurate-treatment

Lactation Risk Summary: There are no data on the presence of deutetrabenazine or its metabolites in human milk, the effects on the breastfed infant, or the effects of the drug on milk production. The …

Up to 30% of patients taking antipsychotics may develop tardive dyskinesia (TD). Recent evidence-based recommendations demonstrate an unmet need for effective TD management. This systematic …